XRTX XORTX Therapeutics Inc.
Healthcare$2.37+8.72%ClosedMarket Cap: $660,019
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.39
P/S
0.00
EV/EBITDA
-0.13
DCF Value
$3.44
FCF Yield
-349.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-135.3%
ROA
-128.3%
ROIC
-238.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-811.9K | $-797.3K | $— | — |
| Q4 null | $0.00 | NaN% | $-686.4K | $-590.5K | $— | — |
| FY null | $0.00 | NaN% | $-3.3M | $-2.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-716.2K | $-649.5K | $— | — |
| Q2 null | $0.00 | NaN% | $-889.9K | $-717.7K | $— | — |
| Q1 null | $0.00 | NaN% | $-963.5K | $-698.7K | $— | — |
| Q4 null | $0.00 | NaN% | $-661.3K | $122.5K | $— | — |
| FY null | $0.00 | -Infinity% | $-5.6M | $-4.5M | $— | — |
| Q3 null | $0.00 | NaN% | $0.00 | $-587.0K | $— | — |
| Q2 null | $0.00 | NaN% | $-3.1M | $170.1K | $— | — |
| Q1 null | $0.00 | -Infinity% | $-795.7K | $-3.0M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-862.2K | $2.7M | $30.50 | — |